Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Sutrovax Inc
Profile last edited on: 6/26/18      CAGE: 71JJ6      UEI: Y56EGX9CCTE5

Business Identifier: Conjugate vaccines and novel complex antigen-based vaccines to prevent serious infectious diseases.
Year Founded
2013
First Award
2016
Latest Award
2016
Program Status
Inactive
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

353 Hatch Drive
Foster City, CA 94404
   (650) 837-0111
   info@sutrovax.com
   www.sutrovax.com
Location: Single
Congr. District: 14
County: San Mateo

Public Profile

Spun out of Sutro Biopharma with an exclusive license to Sutro Biopharma’s Xpress CF™ platforms for cell free protein synthesis and site-specific conjugation, SutroVax is an independent biopharmaceutical company developing vaccines for infectious disease targets with an initial emphasis on best-in-class conjugate vaccines and protein-based vaccines. Developing vaccines for infectious disease targets and with an initial emphasis on conjugate vaccines, using an exclusive license to Sutro Biopharma’s Xpress CF™ and Xpress CF+™ platforms for cell free protein synthesis and site-specific conjugation resp

Extent of SBIR involvement

User Avatar
Phase I Awards
1
Phase II Awards
0
Conversion Rate
0.00%
Phase I Dollars
$196,063
Phase II Dollars
$0
Total Awarded
$196,063

Synopsis: Awardee Business Condition

Employee Range
25-49
Revenue Range
2.5M-5M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2016 1 NIH $196,063
Project Title: Development of a Universal Influenza Vaccine Produced by Cell-Free Protein Synthesis

Key People / Management

  Grant E Pickering -- Founder, President and CEO

  Durga Bobba -- Chief Business Officer

  Jeff C Fairman

  Alan Kimura -- Chief Medical Officer

  Aron Stein -- Vice President of Regulatory Affairs & Quality Assurance.

  Elaine D Sun

Company News

Jul 23 2015
SutroVax, a South San Francisco, CA-based biopharmaceutical vaccine company, completed a $22m Series a financing.